多种ERBB2/ERBB3激活变异和协同变异对整个固体瘤的HER2/3向治疗有影响
Dazhi Liu1, Justin Jee1, Alexander Drilon1,2
1Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer research communications
|April 3, 2025
概括
综合基因组分析 (CGP) 在许多癌症中揭示了各种ERBB2 / HER2变异,扩大了HER2导向疗法的潜在点,超出了目前的批准. 这种方法比传统的个性化癌症治疗方法提供了更深入的基因组洞察力.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症生物标志物 癌症生物标志物
背景情况:
- ERBB2 (HER2) 是各种癌症的关键瘤驱动因素和生物标志物,但目前的疗法只针对其变化的有限范围.
- 像IHC和FISH这样的传统方法评估HER2状态,但缺乏基因组背景,可能缺少可操作的突变.
研究的目的:
- 通过使用综合基因组分析 (CGP) 来定义激活ERBB2和ERBB3基因组改变的泛瘤景观.
- 识别具有多种ERBB2/ERBB3变异的患者群体,他们可能受益于针对HER2的疗法,包括非标签用途.
主要方法:
- 查询了实体瘤CGP的机构数据库,分析了超过429,000个基础医学和83,000个MSK-IMPACT测试的数据.
- 确定了激活ERBB2和ERBB3的改变,包括单核酸变体,插入/删除和放大.
主要成果:
- 在众多癌症类型中发现激活ERBB2/ERBB3变异,许多目前尚未批准用于针对HER2的疗法.
- 非小细胞肺癌显示ERBB2突变癌的比例最高 (19.0%),而乳腺癌,结直肠癌,膀癌和胃食道癌占ERBB2突变瘤的50.4%.
- 在非小细胞肺癌中确定了显著的ERBB2变化,这些变化未被trastuzumab deruxtecan临床试验所涵盖.
结论:
- CGP为HER2状态提供了关键的基因组背景,检测出IHC/FISH错过的突变和共同改变.
- 这些发现突显了尚未满足的治疗需求,并支持基于CGP结果的HER2向疗法的更广泛应用.
- CGP使HER2状态的解释更加细致,指导个性化治疗策略并改善患者的治疗结果.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.1K
相关概念视频
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
